Insiders Of China NT Pharma Group Are Up 182% On Their CN¥48.4m Purchase

Insiders who bought China NT Pharma Group Company Limited (HKG:1011) stock in the last 12 months were richly rewarded last week. The company's market value increased by HK$81m as a result of the stock's 15% gain over the same period. In other words, the original CN¥48.4m purchase is now worth CN¥136.3m. Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. The Last 12 Months Of Insider Transactions At China NT Pharma Group The insider Iat Ieong made the biggest insider purchase in the last 12 months. That single transaction was for HK$48m worth of shares at a price of HK$0.33 each. Even though the purchase was made at a significantly lower price than the recent price (HK$0.93), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! See our latest analysis for China NT Pharma Group SEHK:1011 Insider Trading Volume December 24th 2025 China NT Pharma Group is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket. Insider Ownership Of China NT Pharma Group Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that China NT Pharma Group insiders own 35% of the company, worth about HK$216m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment. So What Does This Data Suggest About China NT Pharma Group Insiders? It doesn't really mean much that no insider has traded China NT Pharma Group shares in the last quarter. However, our analysis of transactions over the last year is heartening. It would be great to see more insider buying, but overall it seems like China NT Pharma Group insiders are reasonably well aligned (owning significant chunk of the company's shares) and optimistic for the future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 6 warning signs for China NT Pharma Group you should be aware of, and 3 of them make us uncomfortable. But note: China NT Pharma Group may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.Mobile Infrastructure for Defense and DisasterThe next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.Get the investor briefing before the next round of contractsSponsored On Behalf of CiTech